SCHEMBL8098812

SCHEMBL8098812

Nc1cc(C2(S(=O)(=O)c3ccc(F)cc3)CC2)nc(-c2ccc(NC(=O)NC3CC3)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
EPHX1 P07099 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EPHX2 P34913 8/20 0.42
FAAH O00519 1/20 0.42
CA12 O43570 3/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA9 Q16790 3/20 0.41
CA4 P22748 2/20 0.41
CA7 P43166 2/20 0.41
RORC P51449 2/20 0.40
MAPT P10636 1/20 0.40
XBP1 P17861 1/20 0.40
HTT P42858 1/20 0.40
ALDH1A1 P00352 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8093179 0.91 RAB9A (0.42) NPC1RAB9AEPHX1MEN1KMT2A
SCHEMBL8099405 0.90 EPHX1 (0.42) RAB9AEPHX1MEN1KMT2AEPHX2
SCHEMBL8099487 0.90 CA12 (0.42) NPC1RAB9AEPHX1MEN1KMT2A
SCHEMBL8099954 0.89 ABL1 (0.40) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL8083973 0.88 ALDH1A1 (0.43) NPC1RAB9AMEN1KMT2ACA12
SCHEMBL8090573 0.88 PIK3CA (0.40) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL8098814 0.88 EPHX1 (0.47) NPC1RAB9AEPHX1MEN1KMT2A
SCHEMBL8084016 0.88 CA12 (0.41) RAB9AEPHX1MEN1KMT2ASMN1; SMN2
SCHEMBL8084833 0.88 CA12 (0.43) NPC1RAB9AEPHX1MEN1KMT2A
SCHEMBL8090948 0.88 CA12 (0.41) RAB9AEPHX1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed